CAS No.: 1206514-62-6
PL265/PL265酰胺 Catalog No. CSN20566
PL265 is a preclinical, long-acting dual enkephalinase inhibitor (DENKi), with analgesic potential and has been developed as a therapeutic for control of intractable cancer pain.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Gonzalez-Rodriguez S, Poras H, et al. Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain. Scand J Pain. 2017 Jan;14:25-38.
- [2] Bonnard E, Poras H, et al. Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain. Eur J Pharmacol. 2016 Oct 5;788:176-182.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1206514-62-6 | 储存条件 |
|
|
| 分子式 | C27H35N2O9P | 运输 | 蓝冰 | |
| 分子量 | 562.55 | 别名 |
